Snowball logo
logo
ENTO

Entero Therapeutics, Inc.

ENTO β€’ NASDAQ
$2.85$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20202021202220232024TTM
Revenue
Total revenue
------
COGS
0.5711450.53740.1062070.0293--
Gross Profit
(0.571145)(0.5374)(0.106207)(0.0293)--
Operating Expenses & Income
Operating Income
(26.43)(59.06)(12.68)(15.77)(0.0156)(3.598548)
Total Operating Expenses
26.4356.712.6815.770.01563.598548
R&D Expenses
19.1438.320.6912575.0332180.0009040.0546
Selling General & Admin Expenses
7.29476418.3811.9910.740.01463.543998
Earnings from Continuing Operations
Interest Expense
(5.840614)(0.0112)(0.0159)(0.0225)-(0.09)
Interest Income
0.0004840.0011730.0084150.002531--
Income Tax Expense
15.1126.520.1265650.326367-10.6
Net Income
Net Income
(32.67)(58.54)(14.63)(15.79)(18.06)(15.65)
Supplemental
EBIT
(26.83)(58.53)(14.61)(15.77)(0.0156)-
EBITDA
(26.26)(57.99)(14.58)(15.74)0.0333(3.707365)
In millions of USD, except % and values per 1 share